Freudenberg Medical Expands Biopharma Line with Single-Use Assemblies Freudenberg Medical has broadened its biopharma product portfolio to include custom single-use assemblies, a strategic move that leverages the company's extensive expertise in silicone extrusion and molding processes. This
The June 2024 quarter marked a period of substantial financial growth and strategic advancements for Melbourne-based pharmaceutical manufacturer IDT. The company's impressive performance can be attributed to its focus on three core pillars: Advanced Therapies, Active Pharmaceutical Ingredient (API)
The introduction of generative artificial intelligence (AI) into the life sciences manufacturing sector heralds a new era of innovation and efficiency. With the life sciences field continuously pushing for faster product launches, increased production capacity, enhanced supply chain security, and
Phlow Corp., a company dedicated to advancing the Richmond region into a hub for pharmaceutical manufacturing, is making significant strides as it raises $25 million from investors. Following the initiation of its medicine ingredients manufacturing operations in Petersburg last year, this
In a recent significant development set to change the healthcare landscape, Germfree and Orgenesis Inc. have joined forces. This strategic partnership establishes a noble ambition: to revolutionize the production of much-needed cell and gene therapies. The aim is clear—to enhance the availability
In a bold move to expand its immunology portfolio, Johnson & Johnson has announced the acquisition of Proteologix, Inc. for an $850 million upfront payment, with additional milestone payments on the horizon. This strategic purchase positions Johnson & Johnson at the forefront of biotechnological
